首页> 外文期刊>Biomaterials >Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels.
【24h】

Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels.

机译:工程化纤维蛋白原结合的VSV-G包膜,用于通过纤维蛋白水凝胶进行空间和细胞控制的慢病毒递送。

获取原文
获取原文并翻译 | 示例
           

摘要

We recently demonstrated that fibrin hydrogels can be used as vehicles for efficient lentivirus gene delivery. Gene transfer in fibrin gels was strongly dependent on matrix degradation by target cells but a fraction of lentiviral particles diffused out of the gels over time compromising spatial control of gene transfer. To overcome this challenge, we engineered lentiviral particles that bind covalently to fibrin during polymerization. To this end, we fused into the viral envelope glycoprotein (VSV-G) peptide domains that are recognized by factor XIII and protease cleavage sites that are recognized by plasmin. Lentivirus pseudotyped with the modified envelopes bound to fibrinogen in a factor XIII dose dependent manner and was released upon plasmin treatment. The peptide/VSV-G fusion envelope variants did not compromise the transduction efficiency of the resulting virus except when lacking any flexible linkers separating the peptide from the VSV-G envelope. Diffusion of virus from the gels decreased dramatically, especially at high concentrations of FXIII, even for fibrin gels with low fibrinogen concentration that were loaded with high titer virus. Lentivirus arrays prepared with fibrin-conjugated lentivirus yielded highly efficient gene transfer that was confined to virus-containing fibrin spots. As a result, signaloise ratio increased and cross-contamination between neighboring sites was minimal. Finally, in addition to lentivirus microarrays this strategy may be used to achieve spatially-controlled gene transfer for therapeutic applications.
机译:我们最近证明了纤维蛋白水凝胶可以用作有效的慢病毒基因传递的载体。纤维蛋白凝胶中的基因转移在很大程度上取决于靶细胞对基质的降解,但是随着时间的流逝,一部分慢病毒颗粒会从凝胶中扩散出去,从而损害了基因转移的空间控制能力。为了克服这一挑战,我们设计了在聚合过程中与血纤蛋白共价结合的慢病毒颗粒。为此,我们将XIII因子识别的病毒包膜糖蛋白(VSV-G)肽域与纤溶酶识别的蛋白酶切割位点融合在一起。用修饰的包膜假型化的慢病毒以XIII因子剂量依赖性方式与血纤蛋白原结合,并在纤溶酶处理后释放。肽/ VSV-G融合包膜变体不会损害所得病毒的转导效率,除非缺少将肽与VSV-G包膜分开的柔性接头。病毒从凝胶中的扩散显着降低,尤其是在高浓度的FXIII时,即使对于载有高滴度病毒的低纤维蛋白原浓度的纤维蛋白凝胶也是如此。用结合了血纤蛋白的慢病毒制备的慢病毒阵列产生了高效的基因转移,该基因转移仅限于含病毒的血纤蛋白斑点。结果,信噪比增加,相邻站点之间的交叉污染最小。最后,除了慢病毒微阵列,该策略还可用于实现空间控制的基因转移以用于治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号